Rockwell Medical Inc
RMTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.87M
Close$
$4.44
19.9% downside
Current Fair Value
19.9% downsideOvervalued by 19.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.87 Million |
|---|---|
| Enterprise Value | $-23,856,435,454.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.5 |
| Beta | 1.62 |
| Outstanding Shares | 3,941,830 |
Return
| Return on Equity | -19291.87% |
|---|---|
| Return on Assets | -12046.54% |
| Return on Invested Capital | -3958.29% |
Valuation & Multiples
| P/E Ratio | -3.73 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.62 |
| Enterprise Value to Revenue | -0.28 |
| Enterprise Value to EBIT | 12.67 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$17.95 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$17.84 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6633▲ 66.33% |
|---|---|
| Total Calls | 19,600▼ 69.89% |
| Total Puts | 13,000▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.09%▲ 0.39% |
|---|---|
| Total Invested | $3.55M▲ 21.93% |
| Investors Holding | 44▲ 6.00% |
ESG Score
No data
About Rockwell Medical Inc
CEO: Russell Ellison